Combined treatment gamma knife radiosurgery and immunotherapy in a patient with brain metastases from malignant melanoma

Melanoma is a complex disease with a high propensity for brain metastatic spread. Gamma Knife radiosurgery (GKRS) is a minimally invasive procedure to treat intracranial metastasis with a high rate of local tumor control. In this report, we describe the ongoing management of a patient with the development of brain metastases that required GKRS procedures for a total of 17 brain metastases receiving concurrent immunotherapy with pembrolizumab. The first imaging of the patient showed better local control after GKRS. Combined management with immunotherapy and GKRS for brain metastases resulted in extended survival while preserving neurological function and reducing adverse treatment effects in a patient with advanced metastatic brain melanoma.

Authors

Publication Details

Journal
Journal of Endourology and Minimally Invasive Surgery
Published
2024-10-01
DOI
https://doi.org/10.57045/jemis/1211024.pp68-72
Primary Topic
Brain Metastases and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Combined treatment gamma knife radiosurgery and immunotherapy in a patient with brain metastases from malignant melanoma

K. Zhelev, Maria M. Mihaylova, Maria Cholakova
Journal of Endourology and Minimally Invasive Surgery
Brain Metastases and Treatment
article

Combined treatment gamma knife radiosurgery and immunotherapy in a patient with brain metastases from malignant melanoma

K. Zhelev, Maria M. Mihaylova, Maria Cholakova
article en

Abstract

Melanoma is a complex disease with a high propensity for brain metastatic spread. Gamma Knife radiosurgery (GKRS) is a minimally invasive procedure to treat intracranial metastasis with a high rate of local tumor control. In this report, we describe the ongoing management of a patient with the development of brain metastases that required GKRS procedures for a total of 17 brain metastases receiving concurrent immunotherapy with pembrolizumab. The first imaging of the patient showed better local control after GKRS. Combined management with immunotherapy and GKRS for brain metastases resulted in extended survival while preserving neurological function and reducing adverse treatment effects in a patient with advanced metastatic brain melanoma.

Journal of Endourology and Minimally Invasive SurgeryVol. 12(1)
Good health and well-being
Openalex Percentile: Top 58%
Brain Metastases and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.